Text Size
1187 studies found for:    VEGF

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Anterior and Posterior Segment Vascular Changes Following Laser and Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Diabetic Retinopathy
Condition: Diabetic Macular Edema
Intervention:
2 Enrolling by invitation Vascular Endothelial Growth Factor Levels in Ectopic Pregnancy
Condition: Complication Following Ectopic Pregnancy
Intervention:
3 Recruiting Prospective Randomized Trial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)
Condition: Exudative Age-related Macular Degeneration
Interventions: Drug: 24GyE proton and Anti-VEGF;   Drug: 16GyE and anti-VEGF;   Drug: Sham Irradiation and anti-VEGF
4 Completed
Has Results 		Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)
Condition: Macular Degeneration
Intervention: Biological: aflibercept injection (VEGF Trap-Eye, BAY86-5321)
5 Unknown † Does Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)?
Conditions: Choroidal Neovascularization;   Age-Related Macular Degeneration
Intervention: Genetic: VEGF genotyping
6 Completed Omega-3 Supplementation and Vitreal VEGF Levels in Wet-AMD
Condition: Exudative Age-related Macular Degeneration.
Interventions: Dietary Supplement: Anti-VEGF plus AREDS-2;   Dietary Supplement: Anti-VEGF plus AREDS-1
7 Completed Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema
Condition: Diabetic Macular Edema
Intervention: Drug: VEGF Trap-Eye
8 Withdrawn Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients
Conditions: Glioma;   Meningioma
Intervention: Procedure: Blood test
9 Active, not recruiting Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy
Condition: Wet AMD
Intervention:
10 Completed
Has Results 		Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)
Condition: Macular Degeneration
Interventions: Biological: ranibizumab;   Biological: aflibercept injection (VEGF Trap-Eye, BAY86-5321)
11 Completed VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Primary Peritoneal Cavity Cancer;   Recurrent Ovarian Epithelial Cancer
Interventions: Drug: docetaxel;   Biological: ziv-aflibercept;   Other: laboratory biomarker analysis;   Other: pharmacological study
12 Completed Angiogenesis Using VEGF-A165/bFGF Plasmid Delivered Percutaneously in No-option CAD Patients; a Controlled Trial
Condition: Coronary Artery Disease
Intervention: Genetic: intramyocardial injection of VEGF-A165/bFGF:placebo plasmid
13 Withdrawn A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.
Conditions: Carcinoma, Renal Cell;   Glioblastoma;   Carcinoma, Hepatocellular
Interventions: Drug: Crizotinib plus VEGF inhibitor combinations;   Drug: Crizotinib plus axitinib;   Drug: Crizotinib plus sunitinib;   Drug: Crizotinib plus bevacizumab;   Drug: Crizotinib plus sorafenib
14 Recruiting EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction
Conditions: Pre-eclampsia;   Intra-uterine Growth Retardation
Intervention: Other: blood sample and doppler Ultrasound of uterine arteries
15 Completed Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD
Condition: Macular Degeneration
Intervention: Drug: VEGF Trap
16 Completed
Has Results 		Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer
Condition: Rectal Cancer
Interventions: Drug: Avastin (Bevacizumab, RHUMAB VEGF);   Drug: Capecitabine;   Radiation: Radiation Therapy
17 Recruiting Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement
Condition: Macular Edema
Interventions: Biological: VEGF Trap-Eye (BAY86-5321);   Procedure: Laser photocoagulation
18 Completed
Has Results 		Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)
Condition: Macular Degeneration
Interventions: Drug: Ranibizumab;   Biological: Aflibercept Injection (EYLEA, VEGF Trap-Eye, BAY86-5321)
19 Completed
Has Results 		Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)
Condition: Retinal Vein Occlusion
Interventions: Biological: Aflibercept Injection (EYLEA, VEGF Trap-Eye, BAY86-5321);   Other: Sham treatment
20 Completed Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)
Condition: Macular Edema Secondary to Central Retinal Vein Occlusion
Interventions: Biological: VEGF Trap-Eye 2.0mg;   Drug: Sham
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years